Results 11 to 20 of about 341 (82)

Modified Delphi study of ultrasound signs associated with placenta accreta spectrum

open access: yesUltrasound in Obstetrics &Gynecology, Volume 61, Issue 4, Page 518-525, April 2023., 2023
ABSTRACT Objective To determine, by expert consensus through a modified Delphi process, the role of standardized and new ultrasound signs in the prenatal evaluation of patients at high risk of placenta accreta spectrum (PAS). Methods A systematic review of articles providing information on ultrasound imaging signs or markers associated with PAS was ...
E. Jauniaux   +39 more
wiley   +1 more source

Third‐trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study

open access: yesUltrasound in Obstetrics &Gynecology, Volume 60, Issue 3, Page 381-389, September 2022., 2022
ABSTRACT Objective To evaluate the performance of third‐trimester ultrasound for the diagnosis of clinically significant placenta accreta spectrum disorder (PAS) in women with low‐lying placenta or placenta previa. Methods This was a prospective multicenter study of pregnant women aged ≥ 18 years who were diagnosed with low‐lying placenta (< 20 mm from
N. Fratelli   +42 more
wiley   +1 more source

Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low‐lying placenta and previous uterine surgery

open access: yesUltrasound in Obstetrics &Gynecology, Volume 57, Issue 1, Page 91-96, January 2021., 2021
ABSTRACT Objectives Maternal mortality related to placenta accreta spectrum (PAS) disorders remains substantial when diagnosed unexpectedly at delivery. The aim of this study was to evaluate the effectiveness of a routine contingent ultrasound screening program for PAS.
C. M. Coutinho   +8 more
wiley   +1 more source

The expression and clinical value of GNA13 in invasive placenta accreta spectrum disorders [PDF]

open access: yes
Objective To investigate the expression and significance of Guanine nucleotides binding protein alpha 13 (GNA13) in the late pregnancy peripheral blood and placental tissue of patients with invasive placenta accreta spectrum disorders (PAS).
GAN Yanping   +5 more
core   +1 more source

宫腔粘连诊断及发病机制的研究进展

open access: yesZhongguo shiyan zhenduanxue, 2021
原因导致子宫内膜基底层受损,子宫腔或宫颈不同程度粘连或闭塞。主要病理学变化是子宫内膜纤维瘢痕化。临床表现包括月经量减少、闭经、周期性腹痛、不孕以及妊娠后胎盘植入等。随着人工流产数量的增加,诊断方法的进步,IUA患病率正逐渐上升。本文就有关IUA的临床发病机制、诊断标准、辅助检测手段等方面的研究进展做一综述,旨在加强和提高对该病的认识,避免过度的诊疗,改善患者的生育质量。1 IUA发病原因及机理1 ...
王娜   +4 more
doaj  

Exploring pathophysiological insights to improve diagnostic utility of ultrasound markers for distinguishing placenta accreta spectrum from uterine‐scar dehiscence

open access: yesUltrasound in Obstetrics &Gynecology, Volume 65, Issue 1, Page 85-93, January 2025.
ABSTRACT Objective Accurate differentiation between placenta accreta spectrum (PAS) and uterine‐scar dehiscence with underlying non‐adherent placenta is often challenging, even for PAS experts, both prenatally and intraoperatively. We investigated the use of standardized two‐dimensional grayscale ultrasound and Doppler imaging markers in ...
T. Adu‐Bredu   +3 more
wiley   +1 more source

常用影像学检查对胎盘植入的诊断价值

open access: yesZhongguo shiyan zhenduanxue, 2016
胎盘植入是一种异常的胎盘附着形式,是导致产妇产后大出血的主要原因之一。近年来,随着剖宫产率的增高,胎盘植入(placenta accrete)的发生率也逐渐升高。广义的胎盘植入根据胎盘绒毛侵入子宫肌层深度分为3类:粘连性胎盘植入(placenta accrete vera)、植入性胎盘植入(placenta increta)、穿透性胎盘植入(placenta perccreta)[1 ...
姚立英, 李增彦
doaj  

磁共振在胎盘植入诊断中的应用

open access: yesZhongguo shiyan zhenduanxue, 2016
胎盘植入是指胎盘蜕膜发育不良导致胎盘绒毛组织侵入子宫肌层,严重者侵及浆膜层,甚至可能涉及相邻盆腔器官[1]。胎盘植入是孕产妇围产期大出血及产后子宫切除不可忽视的原因,是孕产妇发病和死亡的一个重要因素。胎盘植入患病率日趋上升,可能与高龄孕妇比例增加,及以往流产和/或剖宫产史有关[2]。准确及时地诊断为临床手术方案的制定提供了重要依据。以往胎盘相关疾病影像学诊断多依靠超声检查 ...
张蓓, 王卓, 童岚, 王继萍
doaj  

聚焦超声技术在妇产科领域的研究与应用

open access: yes, 2019
聚焦超声技术是一种安全、无创、有效、康复快、无放射性的非侵入性治疗技术,当前被广泛应用于子宫肌瘤、子宫内膜异位症、慢性宫颈炎、外阴非上皮性瘤变、异位妊娠、胎盘植入等妇产科疾病的治疗中。
艳霞 王
core   +1 more source

孕中期甲胎蛋白和游离β人绒毛促性腺激素及脐动脉血流变化与不良妊娠结局的关系 [PDF]

open access: yes, 2010
【目的】 探讨孕中期母血清标志物及脐动脉血流用于预测不良妊娠结局的临床价值?【方法】 采用时间分辨荧光分析技术,对876例孕14 ~ 21周的孕妇进行孕中期甲胎蛋白(AFP)?游离β人绒毛促性腺激素(free-β-hCG)检测;对其中536例孕妇在孕14 ~ 28周使用超声多普勒检测其脐动脉血流,并追踪其妊娠结局?用卡方检验比较孕妇血清标志物升高者(342例)?脐动脉血流异常者(82例)?血清标志物升高且脐动脉异常者(40例)之间不良妊娠结局的发生率的差别?【结果 ...

core  

Home - About - Disclaimer - Privacy